Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Peter Kolchinsky’

Peter Kolchinsky

This Biotech Investor’s Picks Returned 31% in Q1; Here Are Its New Bets

Peter Kolchinsky is one of the best biotech investors and many of his stock picks generate strong returns. We calculate a fund’s returns by taking......(read more)
Peter Kolchinsky

Five Stocks To Buy According To Top Biotech-Focused Funds

Biotechnology is a very interesting industry to invest in, but also very complex. If you are looking for stocks that are most likely to see their value......(read more)
Countries with Highest Natural Gas Reserves

Big Insider Buying at Hot IPO Solid Biosciences (SLDB), Range Resources (RRC) and General Electric (GE)

With the stock market having been battered in recent days and fears that a large correction may be starting to pick up steam becoming more pronounced,......(read more)
Peter Kolchinsky

Avexis Inc. (AVXS): RA Capital Management Ups Its Stake

Peter Kolchinsky‘s RA Capital Management has slightly raised its stake in Avexis Inc. (NASDAQ:AVXS), as per a new Form 13G with the Securities......(read more)
Peter Kolchinsky

RA Capital Management Slashes Alcobra Ltd (ADHD) Position After FDA Clinical Hold

Peter Kolchinsky‘s RA Capital Management has slashed its position in Alcobra Ltd (NASDAQ:ADHD) to just under 1.31 million shares according to a......(read more)
Peter Kolchinsky

Aclaris Therapeutics Inc (ACRS): RA Capital Management Disposes of 1.1 Million Shares

An amended 13G filing with the SEC revealed that Peter Kolchinsky‘s RA Capital Management has sold around 1.1 million shares of Aclaris Therapeutics......(read more)
Peter Kolchinsky

Protagonist Therapeutics Inc (PTGX): RA Capital Management Acquires 6.8% Stake

Peter Kolchinsky‘s RA Capital Management reported via a recent 13G filing with the SEC that it has taken a new position in a company that has recently......(read more)
Peter Kolchinsky

RA Capital’s Top Q2 Performers; Predicts Big Things Ahead for Pharma Stocks

RA Capital Management LLC is a crossover fund manager that invests in public and private healthcare and life science companies developing drugs, medical......(read more)
Peter Kolchinsky

Vitae Pharmaceuticals Inc (VTAE): RA Capital Management Ups Its Stake

A recent 13G filing with the SEC revealed that Peter Kolchinsky‘s RA Capital Management has acquired more shares of Vitae Pharmaceuticals Inc......(read more)
BPMC

Ardelyx (ARDX): RA Capital Management Boosts Stake to 7.7%

Peter Kolchinsky‘s RA Capital Management has stepped up its interest in Ardelyx Inc. (NASDAQ:ARDX). As reported in a recent filing with the Securities......(read more)
Peter Kolchinsky

Peter Kolchinsky Is Betting Big On Achillion Pharmaceuticals, Inc. (ACHN), Wave Life Sciences (WVE) & More Heading Into 2016

Peter Kolchinsky founded RA Capital Management in 2001 and focuses mainly on healthcare stocks. One of the few hedge fund managers who actually holds......(read more)
Peter Kolchinsky

Dalton Investments Proposes 6-Point Action Plan to Eros, While Eminence Capital Reveals New Stake in This Hotel Operator

The practice of monitoring quarterly 13F filings has become more popular in recent years, which led to several exchange traded funds (ETFs) being launched......(read more)
Peter Kolchinsky

Two Activist Plays And Two Biotech Moves You Should Check Out

With hedge funds having submitted their 13F filings for the third quarter, people at Insider Monkey are busy compiling the data necessary to identify......(read more)
Peter Kolchinsky

Is Zogenix A Good Stock To Buy Now?

RA Capital Management, led by Peter Kolchinsky, has disclosed a massive new stake in California-based pharmaceutical company Zogenix, Inc (NASDAQ:ZGNX......(read more)
Steve Cohen SAC CAPITAL ADVISORS

Steve Cohen, Peter Kolchinsky Disclose New Stakes In Micro-cap Pharmaceutical Stocks

Steve Cohen’s Point72 Asset Management has initiated a new position in Inotek Pharmaceuticals Corporation (NASDAQ:ITEK). In a freshly-submitted filing......(read more)
Peter Kolchinsky

Peter Kolchinsky’s New Top Healthcare Pick And Old Favorites

Peter Kolchinsky‘s RA Capital Management recently filed its 13F with the SEC for the reporting period of June 30. Peter Kolchinsky started RA Capital......(read more)
Peter Kolchinsky

RA Capital’s Latest Move In Alcobra Ltd (ADHD) Coming Off Hefty Second Quarter Gains

According to a recent filing with the Securities and Exchange Commission, Peter Kolchinsky‘s RA Capital has initiated a position in Alcobra Ltd (......(read more)
Peter Kolchinsky

RA Capital Is Expecting A Breakthrough Cardiovascular Drug From This Biotech

The biotechnology industry is up by more than 50% over the last year, but these towering returns don’t come without great risk and volatility. However......(read more)
Peter Kolchinsky

Ardelyx Inc (ARDX): RA Capital Management Discloses 7.3% Passive Stake

RA Capital Management, led by Peter Kolchinsky, has opened a new position in clinical-stage biopharmaceutical company Ardelyx Inc (NASDAQ:ARDX). A new......(read more)
Chase Coleman Tiger Global Management

Bitauto Hldg Ltd (ADR) (BITA), Aurinia Pharmaceuticals Inc (AUPH): Tiger Global and RA Capital Disclose Their Latest Moves

In a new filing with the Securities and Exchange Commission, Billionaire Chase Coleman‘s Tiger Global disclosed slightly reducing its exposure......(read more)
Peter Kolchinsky

Regulus Therapeutics Inc (RGLS), Trevena Inc (TRVN), Juno Therapeutics Inc (JUNO): RA Capital’s Top New Biotech Picks

Peter Kolchinsky’s RA Capital Management filed its latest 13F with the Securities and Exchange Commission in February, and we’ve gone through the......(read more)
Peter Kolchinsky

Tekmira Pharmaceuticals Corporation (TKMR): RA Capital Management Discloses 10% Passive Stake

It was revealed in a filing yesterday with the U.S Securities and Exchange Commission that RA Capital Management has opened a large, passive position......(read more)
Felix Baker - Baker Bros.

Seattle Genetics Inc. (SGEN), Cerus Corporation (CERS): Baker Bros. Advisors’ Latest Moves

Baker Bros. Advisors, the fund managed by Julian and Felix Baker disclosed changes in two of its activist positions last Thursday. The firm continued......(read more)
Peter Kolchinsky

Synergy Pharmaceuticals Inc (SGYP), Proteon Therapeutics Inc (PRTO): James E. Flynn and Peter Kolchinsky Think These Stocks Look Healthy

Synergy Pharmaceuticals Inc (NASDAQ:SGYP) and Proteon Therapeutics Inc (NASDAQ:PRTO) are in the spotlight as James E. Flynn’s Deerfield Management and......(read more)
Entegris Inc (NASDAQ:ENTG)

Entegris Inc (ENTG), Dicerna Pharmaceuticals Inc (DRNA): GMT Capital and Deerfield Management Report Their Latest Moves

In two new filings, Thomas E. Claugus‘ GMT Capital disclosed further raising its exposure to Entegris Inc (NASDAQ:ENTG). The investor revealed buying......(read more)
Jeffrey Tannenbaum

CIG Wireless Corp (CIGW), Achillion Pharmaceuticals Inc (ACHN): Jeffrey Tannenbaum And Peter Kolchinsky Disclose Their Latest Moves

CIG Wireless Corp (OTCBB:CIGW), an operator of wireless and broadcast communication towers in the United States, has issued approximately 1.25 million......(read more)
Peter Kolchinsky

Achillion Pharmaceuticals Inc (ACHN), Tenax Therapeutics Inc (TENX): Peter Kolchinsky’s Latest Equity Moves

RA Capital Management has continued the sale of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) shares. In a recent wave of reductions, the fund has dumped......(read more)
Peter Kolchinsky

Achillion Pharmaceuticals, Inc. (ACHN): RA Capital Management Sells Over 2 Million Shares

RA Capital Management, managed by Peter Kolchinsky, continues to unload its stake in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN). In a new filing with......(read more)
Ken Griffin

Sunesis Pharmaceuticals, Inc. (SNSS): Ken Griffin’s Citadel Boosts His Stake

Citadel Advisors, a fund managed by Ken Griffin, has disclosed boosting its stake in Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS). Citadel upped its position......(read more)
Peter Kolchinsky

Achillion Pharmaceuticals, Inc. (ACHN): Peter Kolchinsky’s RA Capital Sells Some More Shares

Peter Kolchinsky‘s RA Capital Management, in a new filing with the Securities and Exchange Commission, has disclosed the sale of around 1.70 million......(read more)
Peter Kolchinsky

RA Capital Management Continues To Unload Achillion Pharmaceuticals, Inc. (ACHN) Stock: Sells Further 835,293 Shares

In a new filing with the U.S. Securities and Exchange Commission, RA Capital Management, managed by Peter Kolchinsky, has disclosed holding an 18.1% passive......(read more)
Crispin Odey

Hedge Fund News: Crispin Odey, Peter Kolchinsky & T Boone Pickens

Manchester United Divides Hedge Funds’ Loyalties (WSJ) Some of Europe’s most powerful hedge fund managers are sharply divided on the outlook......(read more)
Peter Kolchinsky

Achillion Pharmaceuticals Inc. (ACHN): RA Capital Management Cuts Stake To 19.0% From 21.1%

RA Capital Management, led by Peter Kolchinsky, disclosed in a newly amended filing with the U.S. Securities and Exchange Commission that it further reduced......(read more)
Hedge Fund Managers

Cognizant Technology Solutions Corp (CTSH), Titan International Inc. (TWI), Salix Pharmaceuticals Ltd. (SLXP) Among Stocks Hedge Funds Are Bullish On

Amidst the 13F filing season, several hedge funds have also been filing Schedule 13G forms, disclosing changes that took place after June 30, 2014, in......(read more)
Peter Kolchinsky

RA Capital Management Sells 800,000 Shares of Achillion Pharmaceuticals Inc. (ACHN)

RA Capital Management, managed by Peter Kolchinsky, has sold 800,000 shares of Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) in two transactions for about......(read more)
Ophthotech

James Litinsky is Bullish on Ophthotech Corp (OPHT); JHL Capital Boosts Stake in the Company

James H. Litinsky‘s JHL Capital Group has boosted its stake in Ophthotech Corp (NASDAQ:OPHT) to 1.78 million shares, a new filing with the SEC......(read more)
Peter Kolchinsky

RA Capital Reports New 5.8% Position In Recently Public Versartis Inc (VSAR)

Peter Kolchinsky’s RA Capital Management has initiated a new position in Versartis Inc (NASDAQ:VSAR). RA Capital owns 1.40 million shares of the company......(read more)
Peter Kolchinsky

Ra Capital Management Reveals New Stake in Enanta Pharmaceuticals Inc (ENTA)

Peter Kolchinsky‘s Ra Capital Management disclosed a new position in Enanta Pharmaceuticals Inc (NASDAQ:ENTA). According to a 13G filing, the......(read more)
Peter Kolchinsky

RA Capital Management Discloses New Stake in SANUWAVE Health Inc. (SNWV); Boosts Position in pSivida Corp. (PSDV)

In two recent filings with the U.S. Securities and Exchange Commission, Peter Kolchinsky’s RA Capital Management has revealed a new position in SANUWAVE......(read more)
Peter Kolchinsky

RA Capital Discloses New Passive Stake in Repros Therapeutics Inc (RPRX)

RA Capital Management, managed by Peter Kolchinsky, has revealed a new position in Repros Therapeutics Inc (NASDAQ:RPRX). RA Capital has disclosed a passive......(read more)
ACADIA Pharmaceuticals Inc. (ACAD)

Baker Bros. Advisors’ Latest Moves Involve ACADIA Pharmaceuticals Inc. (ACAD) & Synageva Biopharma Corp (TRMS)

Julian Baker and Felix Baker’s hedge fund, Baker Bros. Advisors, has recently tweaked its holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) and......(read more)
Peter Kolchinsky

Ra Capital Management Revealed Stake in Dicerna Pharmaceuticals Inc (DRNA) After Deerfield and Brookside

Ra Capital Management, a fund managed by Peter Kolchinsky, disclosed, in a new filing with the Securities and Exchange Commission, that it owns 2.43 million......(read more)
Peter Kolchinsky

Ra Capital Management Initiates Stake in Furiex Pharmaceuticals Inc (FURX) After the Stock Jumped

Peter Kolchinsky‘s Ra Capital Management, has just disclosed initiating a 7.2% stake in Furiex Pharmaceuticals Inc (NASDAQ:FURX). The position......(read more)
OncoGenex Pharmaceuticals Inc (OGXI)

Tang Capital Management Is Getting Out of OncoGenex Pharmaceuticals Inc (OGXI) and Cyclacel Pharmaceuticals Inc (CYCC)

Kevin C. Tang‘s Tang Capital Management has decreased its position it two pharmaceutical companies. The $200 million hedge fund recently decreased......(read more)
02 Jamie Zimmerman

Hedge Fund News: Jamie Zimmerman, Perry Capital & Paul Singer

Women hedge fund managers outpace male rivals, again – study (Reuters UK) Women hedge fund managers have outperformed their male rivals, on average......(read more)
Peter Kolchinsky

Ra Capital Management Lowers Stake in Derma Sciences Inc (DSCI)

Peter Kolchinsky‘s Ra Capital Management has recently sold a total of 300,000 shares of Derma Sciences Inc (NASDAQ:DSCI). Following the disposal......(read more)
BLUE RIDGE CAPITAL

5 Stocks Hedge Funds Bought Recently

Academic research on hedge funds have shown that the stocks bought by hedge funds outperform the market on average. In this article we will focus on 5......(read more)
Peter Kolchinsky

Peter Kolchinsky, Ra Capital Management Inrease Stake in Achillion Pharmaceuticals Again

Peter Kolchinsky‘s hedge fund, Ra Capital Management disclosed upping its position in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) some more.......(read more)
Peter Kolchinsky

Peter Kolchinsky, Ra Capital Buy More Achillion Pharmaceuticals at $2.48/Share

Peter Kolchinsky‘s, RA Capital Management solidified its position in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) even more today. This time,......(read more)
Peter Kolchinsky

Peter Kolchinsky’s RA Capital Has Been Very Active This Month

Since the beginning of November, Peter Kolchinsky‘s RA Capital Management has informed the U.S. Securities and Exchange Commission that it’......(read more)